Trump Just Said “Biotechnology” for the First Time in 353 Days as President
Biotechnology is a $350 billion-a-year industry for the U.S., but until now, President Donald J. Trump has never mentioned it.
Why you should care: Trump hasn’t ever said the words “CRISPR,” “embryo editing,” “eugenics,” or “gene therapy,” either. Biologists are understandably anxious about what he thinks.
What he’s said now: “We are streamlining regulations that have blocked cutting-edge biotechnology, setting free our farmers to innovate, thrive, and to grow,” Trump told a meeting of the American Farm Bureau Federation in Nashville, Tennessee, on January 8. (He added, “Oh, are you happy you voted for me. You are so lucky that I gave you that privilege.”)
He’s pro-GMO? Sounds like it. KFC-loving Trump may have been referring to how, in November, his administration scrapped USDA rules that would have regulated plants created through gene-editing tools like CRISPR.
In an e-mail, a spokesperson for the Biotechnology Innovation Organization, the industry’s trade group, confirmed it was the first time Trump has uttered the word as president.
Deep Dive
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
How AI can help us understand how cells work—and help cure diseases
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.